Skin Care Brand Warned By FDA To Stop Advertising Product As A Drug
September 12, 2012

Skin Care Brand Warned By FDA To Stop Advertising Product As A Drug

Lawrence LeBlond for - Your Universe Online

Cosmetics giant L´Oreal is being warned by federal regulators that it cannot advertise its skin care products using language that makes them appear to be like drugs with beneficial medical properties.

The issue arose when the Food and Drug Administration (FDA) found French skin care company L´Oreal was misleading customers of its Lancome line of anti-aging products, advertising the products in a way that the regulatory agency said violates US law. The company claimed some of its skin creams could “boost the activity of genes” or “stimulate cell regeneration” to reduce signs of aging.

The FDA warning affects a number of L´Oreal products, including Genefique Youth Activating Concentrate, a popular anti-wrinkle cream that the company has portrayed as a drug with medical properties.

The regulator said on its website that “any product that is intended to affect the structure or function of the human body is classified as a drug.” And companies are not allowed to sell drugs in the US without first demonstrating to the FDA that the product in question is both safe and effective--to which L´Oreal has not done.

Lancome and L´Oreal have 15 days to respond to the FDA warning with specific steps it has taken to correct the language violation. If  appropriate actions are not taken to fix the illegal claims, the FDA could take enforcement actions, such as seizure of the products and place injunctions against their manufacturers and distributors, according to a Reuters report.

A spokeswoman for L´Oreal said the company was committed to complying with all laws and regulations and would respond to the FDA´s letter in a timely fashion.